
35 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Albers, Vascular Neurologist in Stanford, CA?
Dr. Gregory Albers, MD is a Vascular Neurologist, who primarily practices in Stanford, CA with 1 additional practice location. He has been practicing for over 35 years and is board certified. Dr. Albers graduated from University of California and completed his residency at Stanford University Hospital. Dr. Albers is fluent in English and Spanish, and is currently seeing new patients. Dr. Albers’s practice accepts Kaiser Permanente, Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Albers’s office at (650) 723-4000.
Where did Dr. Albers go to medical school and complete their residency?
Residency: Stanford University Hospital
Medical School: University of California
Is Dr. Albers board certified as a Vascular Neurologist?
Yes, Dr. Gregory Albers, MD is board certified by the American Board of Psychiatry and Neurology
What languages does Dr. Albers speak?
Dr. Albers and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Vascular Neurologist like Dr. Albers typically treat?
As a Vascular Neurologist, Dr. Albers diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Albers. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Ischemic Stroke
- Mini-Stroke
- Long-Term Effects of Ischemic Stroke
- Stroke
- Transient Ischemic Attack
- Brain Attack
- Cerebral Infarction
- Brain Ischemia
- TIA
- Warning Stroke
- Lack of Blood Flow to Brain
- Stroke due to clot
- Post-ischemic stroke complications
- Stroke after-effects
- Residual problems from brain infarction
- Ischemic stroke sequelae
ICD-10 Codes:
- I639: Cerebral infarction, unspecified
- Z8673: Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits
- I6381: Other cerebral infarction due to occlusion or stenosis of small artery
- I6930: Unspecified sequelae of cerebral infarction
Also known as:
- Transient Ischemic Attack
- Mini-Stroke
- Warning Stroke
ICD-10 Codes:
- G459: Transient cerebral ischemic attack, unspecified
Also known as:
- High Cholesterol
- Cholesterol
- Triglycerides
- Hyperlipidemia
- High lipids
- Dyslipidemia
ICD-10 Codes:
- E785: Hyperlipidemia, unspecified
Also known as:
- Dizziness
- Dizziness and Vertigo
- Lightheadedness
- Giddiness
- Vertigo
ICD-10 Codes:
- R42: Dizziness and giddiness
Also known as:
- Organ-Limited Amyloidosis
- Amyloidosis
- Amyloidosis & Kidney Disease
- Localized Amyloidosis
- Amyloid Deposit in Organ
ICD-10 Codes:
- E854: Organ-limited amyloidosis
Also known as:
- Intracerebral Hemorrhage
- Hemorrhagic Stroke
- Brain bleed
- ICH
- Bleeding in the brain
ICD-10 Codes:
- I610: Nontraumatic intracerebral hemorrhage in hemisphere, subcortical
What procedures does a Vascular Neurologist like Dr. Albers typically perform?
As a Vascular Neurologist, procedures performed by Dr. Gregory Albers may include:
- Aging Brain (Neuropsychological Testing)
- Cortical Basal Ganglionic Degeneration (CBGD)
- Deep Brain Stimulation
- Disturbance of Skin Sensation
- Electroencephalogram (EEG)
- Evoked Potential Testing
- Gait Simulation
- Greater Occipital Nerve (GON) Block
Please contact Dr. Albers' office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Albers accept my insurance?
Dr. Albers accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Albers accept in Stanford, CA?
Dr. Albers in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
AllCare Health
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Medicaid
Medicare
State of California
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Albers' office located?
Recognitions
Publications
Effect of collateral blood flow on patients undergoing endov
, 2014
Early diffusion-weighted imaging reversal after endovascular reperfusion is typically transient in
, 2014
Hypoperfusion Intensity Ratio Predicts Infarct Progression
, 2014
Patients with single distal MCA perfusion lesions have a high rate of good outcome
, 2014
Radiological examitions of transient ischemic attack.
, 2014
Pilot Study of Intravenous Glyburide in Patients With a Large Ischemic Stroke
, 2014
THRIVE Score Predicts Outcomes With a Third
, 2013
Stroke Treatment Academic Industry Roundtable Research Priorities
, 2013
Imaging Recommendations for Acute Stroke and Transient Ischemic Attack Patients
, 2013
Imaging recommendations for acute stroke and transient ischemic attack patients
, 2013
Imaging Recommendations for Acute Stroke and Transient Ischemic Attack Patients
, 2013
Reduction in Early Stroke Risk in Carotid Stenosi
, 2013
Recommendations on Angiographic Revascularization Grading St
, 2013
Acute Stroke Imaging Research Roadmap II
, 2013
Comparison of the response to endovascular reperfusion in relation to site of arterial occlusion.
, 2013
Validating Imaging Biomarkers of Cerebral Edema in Patients With Severe Ischemic Stroke
, 2013
Impact of diffusion-weighted imaging lesion volume on the success of endovascular reperfusion
, 2013
Clinical outcomes strongly associated with the degree of reperfusion achieved
, 2013
MR RESCUE Is the Glass Half-Full or Half-Empty?
, 2013
Details of a prospective protocol for a collaborative meta
, 2013
Imaging-based selection for intra-arterial stroke therapies.
, 2013
Advanced imaging improves prediction of hemorrhage after stroke thrombolysis
, 2013
Selection of patients for intra-arterial therapy--authors' reply.
, 2013
Early Diffusion-Weighted Imaging
, 2013
Advanced Imaging to Extend the Therapeutic Time Window of Acute Ischemic Stroke
, 2013
The Effects of Alteplase 3 to 6 Hours After Stroke in the EPITHET
, 2013
Apparent diffusion coefficient threshold for delineation of ischemic core.
Impact of recalization, reperfusion, and collateral flow on clinical efficacy.
, 2013
Oral Antithrombotic Agents for the Prevention of Stroke
, 2012
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions
, 2012
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2)
, 2012
The Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program
, 2012
Patients With the Malignt Profile Within 3 Hours of Symptom Onset Have Very Poor Outcomes
, 2012
Clinical Assessment of Standard and Generalized Autocalibrating Partially Parallel Acquisition
, 2012
Combined spin- and gradient-echo perfusion-weighted imaging
, 2012
Comparison of Arterial Spin Labeling
, 2012
Automated Perfusion Imaging for the Evaluation of Transient Ischemic Attack
, 2012
Hemisphere Volume Is Associated with Neurological Deterioration
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
, 2012
Yield of CT perfusion for the evaluation of transient ischaemic attack.
The infarct core is well represented by the acute diffusion lesion
, 2012
Arterial Spin Labeling Imaging Findings in Transient Ischemic Attack Patients
, 2012
MRI guides diagnostic approach for ischaemic stroke
, 2011
Greater Effect of Stroke Thrombolysis in the Presence of Arterial Obstruction
, 2011
Heterogeneity in the penumbra
, 2011
Stroke Treatment Academic Industry Roundtable
, 2011
Improving the Accuracy of Perfusion Imaging in Acute Ischemic Stroke
, 2011
Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA A multicenter study
, 2011
Systemic augmentation of alpha B-crystallin provides therapeutic benefit twelve hours post
, 2011
TWO ACES Transient Ischemic Attack Work-Up as Outpatient Assessment of Clinical Evaluation
, 2011
RAPID Automated Patient Selection for Reperfusion Therapy A Pooled Alysis of the Echoplar Imaging
, 2011
A Topographic Study of the Evolution of the MR DWI
, 2011
Refining the Definition of the Malignt Profile Insights From the DEFUSE-EPITHET Pooled Data Set
, 2011
Role of Diffusion and Perfusion MRI in Selecting Patients for Reperfusion Therapies
, 2011
tiol Stroke Association Recommendations for Systems of Care for Transient Ischemic Attack
, 2011
The Acute Diffusion Lesion Reliably Represents Infarct Core
, 2011
A 5-Item Scale to Predict Stroke Outcome After Cortical Middle Cerebral Artery Territory Infarction
, 2011
TIA Clinic Triage Strategy Reduces the Cost of TIA Evaluation
, 2011
Worse Stroke Outcome In Atrial Fibrillation Links To More Severe Hypoperfusion
, 2011
The Combition Of Reperfusion And Recalization Predicts Favorable Outcome
, 2011
Higher rCBV Values In The PWI
, 2011
Mri Based Tia Triage Study
, 2011
Postthrombolysis hemorrhage risk is affected by stroke assessment bias between hemispheres
, 2011
Diffusion-perfusion MRI for triaging transient ischemic attack and acute cerebrovascular syndromes
, 2011
Fluid-Attenuated Inversion Recovery Hyperintensity in Acute Ischemic Stroke May Not Predict
, 2011
Guidelines for the Prevention of Stroke
, 2011
Study Design of the CLOSURE I Trial A Prospective, Multicenter
, 2010
MRI Profile of the Perihematomal Region in Acute Intracerebral Hemorrhage
, 2010
Real-Time Diffusion-Perfusion Mismatch Alysis in Acute Stroke
, 2010
Addition of brain and carotid imaging to the ABCD
, 2010
Capsular warning syndrome caused by middle cerebral artery stenosis
, 2010
Addition of Brain Infarction to the ABCD(2) Score (ABCD(2)I)
, 2010
Agreement Regarding Diagnosis of Transient Ischemic Attack Fairly Low Among Stroke
, 2010
Combined Arterial Spin Label and Dymic Susceptibility Contrast Measurement of Cerebral Blood Flow
, 2010
Using advanced MRI techniques for patient selection before acute stroke therapy.
, 2010
Dabigatran Challenges Warfarin's Superiority for Stroke Prevention in Atrial Fibrillation
, 2010
Time to treatment with intravenous alteplase and outcome in stroke
, 2010
Validation of the Malignt Profile in the DEFUSE-EPITHET Pooled Database
, 2010
Factors Predicting the Presence of Acute Ischemic Lesions on Diffusion Weighted
, 2010
Diagnostic Accuracy of MRI in Spontaneous Intra-cerebral Hemorrhage (DASH): Initial Results
, 2010
Large and Severe Baseline PWI Volumes Predict Poor Response to Intravenous tPA vs. Placebo in the
, 2010
Symptomatic Intracranial Hemorrhage Rates With IV tPA Treatment by Stroke Subtype
, 2010
DEFUSE and EPITHET: Two Different Studies With One Consistent Message
, 2010